1. Home
  2. HBIO

as of 12-12-2025 3:26pm EST

$0.75
+$0.00
+0.42%
Stocks Industrials Biotechnology: Laboratory Analytical Instruments Nasdaq

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Chart Type:
Time Range:
Founded: 1901 Country:
United States
United States
Employees: N/A City: HOLLISTON
Market Cap: 33.8M IPO Year: 2000
Target Price: $2.50 AVG Volume (30 days): 1.0M
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.22 EPS Growth: N/A
52 Week Low/High: $0.28 - $2.36 Next Earning Date: 11-06-2025
Revenue: $87,371,000 Revenue Growth: -10.60%
Revenue Growth (this year): -6.92% Revenue Growth (next year): 7.22%

AI-Powered HBIO Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 75.17%
75.17%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: